Literature DB >> 14769879

Association of cathepsin E deficiency with development of atopic dermatitis.

Takayuki Tsukuba1, Kuniaki Okamoto, Yoshiko Okamoto, Michiyo Yanagawa, Keiko Kohmura, Yoshiyuki Yasuda, Hiroshi Uchi, Takeshi Nakahara, Masutaka Furue, Keiko Nakayama, Tomoko Kadowaki, Kenji Yamamoto, Keiichi I Nakayama.   

Abstract

Atopic dermatitis (AD) is a pruritic inflammatory skin diseases associated with a family history of atropy. Here we show that mice lacking the endolysosomal aspartic proteinase cathepsin E spontaneously develop skin lesions similar to those of humans with AD when reared under conventional conditions but not under specific pathogen-free conditions. These mice showed the increase in the ratio of CD4+/CD8+ T cells, the strong polarization of naïve T cells to T helper 2 cells, and the systemic accumulation of IL-18 and IL-1beta accompanied by a marked increase in IL-4, IL-5, and IgE. The relative rates of degradation of IL-18 and IL-1beta were significantly lower in cathepsin E-deficient mice than wild-type mice. These results strongly suggest that the development of AD in cathepsin E-deficient mice is initiated by systemic accumulation of IL-18 and IL-1beta, mainly due to their reduced turnover rates. In addition, the reduced expression of cathepsin E was also observed in erythrocytes of both humans with AD and the AD mouse model NC/Nga. Cathepsin E deficiency might thus be responsible for the induction of AD in humans and mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14769879     DOI: 10.1093/jb/mvg216

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  19 in total

Review 1.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

2.  Skin barrier defects in atopic dermatitis.

Authors:  Rachana Agrawal; Judith A Woodfolk
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

3.  The Critical Role of Proteolytic Relay through Cathepsins B and E in the Phenotypic Change of Microglia/Macrophage.

Authors:  Junjun Ni; Zhou Wu; Christoph Peterts; Kenji Yamamoto; Hong Qing; Hiroshi Nakanishi
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

4.  Biochemical characterization and structural modeling of human cathepsin E variant 2 in comparison to the wild-type protein.

Authors:  Vida Puizdar; Tajana Zajc; Eva Zerovnik; Miha Renko; Ursula Pieper; Narayanan Eswar; Andrej Sali; Iztok Dolenc; Vito Turk
Journal:  Biol Chem       Date:  2012-03       Impact factor: 3.915

Review 5.  Animal models of atopic dermatitis.

Authors:  Haoli Jin; Rui He; Michiko Oyoshi; Raif S Geha
Journal:  J Invest Dermatol       Date:  2009-01       Impact factor: 8.551

Review 6.  Itch mechanisms and circuits.

Authors:  Liang Han; Xinzhong Dong
Journal:  Annu Rev Biophys       Date:  2014       Impact factor: 12.981

7.  Regulation of the human cathepsin E gene by the constitutive androstane receptor.

Authors:  Jeanine L Page; Stephen C Strom; Curtis J Omiecinski
Journal:  Arch Biochem Biophys       Date:  2007-08-19       Impact factor: 4.013

Review 8.  Mast cells in atopic dermatitis.

Authors:  Toshiaki Kawakami; Tomoaki Ando; Miho Kimura; Bridget S Wilson; Yuko Kawakami
Journal:  Curr Opin Immunol       Date:  2009-10-14       Impact factor: 7.486

9.  Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors.

Authors:  Anthony J O'Donoghue; Sam L Ivry; Chaity Chaudhury; Daniel R Hostetter; Douglas Hanahan; Charles S Craik
Journal:  Biol Chem       Date:  2016-09-01       Impact factor: 3.915

Review 10.  Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer.

Authors:  Corbin Pontious; Sabrina Kaul; Marcus Hong; Phil A Hart; Somashekar G Krishna; Luis F Lara; Darwin L Conwell; Zobeida Cruz-Monserrate
Journal:  Pancreatology       Date:  2019-09-20       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.